(Exact name of registrant as specified in its charter)
New York
1-2360
13-0871985
(State of Incorporation)
(Commission File Number)
(IRS employer Identification No.)
One New Orchard Road
Armonk, New York
10504
(Address of principal executive offices)
(Zip Code)
914-499-1900
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Capital stock, par value $.20 per share
IBM
New York Stock Exchange
NYSE Chicago
1.125% Notes due 2024
IBM 24A
New York Stock Exchange
2.875% Notes due 2025
IBM 25A
New York Stock Exchange
0.950% Notes due 2025
IBM 25B
New York Stock Exchange
0.875% Notes due 2025
IBM 25C
New York Stock Exchange
0.300% Notes due 2026
IBM 26B
New York Stock Exchange
1.250% Notes due 2027
IBM 27B
New York Stock Exchange
3.375% Notes due 2027
IBM 27F
New York Stock Exchange
0.300% Notes due 2028
IBM 28B
New York Stock Exchange
1.750% Notes due 2028
IBM 28A
New York Stock Exchange
1.500% Notes due 2029
IBM 29
New York Stock Exchange
0.875% Notes due 2030
IBM 30A
New York Stock Exchange
1.750% Notes due 2031
IBM 31
New York Stock Exchange
3.625% Notes due 2031
IBM 31B
New York Stock Exchange
0.650% Notes due 2032
IBM 32A
New York Stock Exchange
1.250% Notes due 2034
IBM 34
New York Stock Exchange
3.750% Notes due 2035
IBM 35
New York Stock Exchange
4.875% Notes due 2038
IBM 38
New York Stock Exchange
1.200% Notes due 2040
IBM 40
New York Stock Exchange
4.000% Notes due 2043
IBM 43
New York Stock Exchange
7.00% Debentures due 2025
IBM 25
New York Stock Exchange
6.22% Debentures due 2027
IBM 27
New York Stock Exchange
6.50% Debentures due 2028
IBM 28
New York Stock Exchange
5.875% Debentures due 2032
IBM 32D
New York Stock Exchange
7.00% Debentures due 2045
IBM 45
New York Stock Exchange
7.125% Debentures due 2096
IBM 96
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
The registrant’s press release dated April 24, 2024, regarding its financial results for the period ended March 31, 2024, including consolidated financial statements for the period ended March 31, 2024, is Exhibit 99.1 of this Form 8-K.
In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has disclosed in the attached press release certain non-GAAP information which management believes provides useful information to investors. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the press release, which is Exhibit 99.1 to this Form 8-K. The rationale for management’s use of non-GAAP measures is included in Exhibit 99.2 to this Form 8-K.
The information in this Item 2.02, including the corresponding Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are being furnished as part of this report:
The following exhibit is being filed as part of this report:
Exhibit No.
Description of Exhibit
104
Cover Page Interactive Data File (embedded within the Inline XBRL Document)
IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.